Coegin Pharma Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Public

  • Employees
  • 3

Employees

  • Stock Symbol
  • 7Z6

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $0.19
  • (As of Friday Closing)

Coegin Pharma General Information

Description

Coegin Pharma AB is a Swedish biotechnology company with projects in hair growth, skin pigmentation, heart attacks, and leukemia. Its project portfolio builds on three distinct, patented technology platforms: the FOL peptide technology, the pigmentation peptide technology, and the cPLA2 alpha technology. The company's project portfolio consists of both cosmetic dermatology and drug development projects. Currently, it is focused on the cosmetic dermatology projects, which include the NPP-4 project for skin pigmentation and the Follicopeptide project for hair growth. In addition, the company's project portfolio also includes three drug development projects: FOL026, for the treatment of myocardial infarction (heart attack); AVX420 for the treatment of leukemia; and AVX001.

Contact Information

Formerly Known As
Avexxin
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • Medicon Village
  • 223 81 Lund
  • Sweden
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Stock Exchange
FRA
Vertical(s)
Corporate Office
  • Medicon Village
  • 223 81 Lund
  • Sweden

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Coegin Pharma Stock Performance

As of 13-Nov-2026, Coegin Pharma’s stock price is $0.19. Its current market cap is $5.76M with 30.7M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.19 $0.18 $0.16 - $0.63 $5.76M 30.7M 312.16 -$0.09

Coegin Pharma Financials Summary

As of 30-Jun-2026, Coegin Pharma has a trailing 12-month revenue of $46.2K.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 8,699 9,026
Revenue 46 8 0 0
EBITDA (1,988) (1,775) (1,920) (2,345)
Net Income (2,318) (2,086) (2,249) (2,632)
Total Assets 833 1,450 2,451 1,544
Total Debt 0 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Coegin Pharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Coegin Pharma‘s full profile, request access.

Request a free trial

Coegin Pharma Patents

Coegin Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4823538-A1 Pharmaceutical composition Pending 15-Dec-2023
WO-2025125241-A1 Pharmaceutical composition Inactive 15-Dec-2023
WO-2023218095-A1 Agents for stimulating tissue regeneration Inactive 13-May-2022
EP-4522191-A1 Agents inducing vascularisation Pending 13-May-2022
US-20250326799-A1 Agents inducing vascularisation Inactive 13-May-2022 C07K7/64
To view Coegin Pharma’s complete patent history, request access »

Coegin Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Coegin Pharma Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Coegin Pharma‘s full profile, request access.

Request a free trial

Coegin Pharma Acquisitions (1)

Coegin Pharma’s most recent deal was a Merger/Acquisition with Follicum. The deal was made on 07-Feb-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Follicum 07-Feb-2022 Merger/Acquisition Drug Discovery
To view Coegin Pharma’s complete acquisitions history, request access »

Coegin Pharma ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Coegin Pharma’s complete esg history, request access »

Coegin Pharma Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Reccura Therapeutics Trondheim, Norway 2005

Coegin Pharma FAQs

  • When was Coegin Pharma founded?

    Coegin Pharma was founded in 2005.

  • Where is Coegin Pharma headquartered?

    Coegin Pharma is headquartered in Lund, Sweden.

  • What is the size of Coegin Pharma?

    Coegin Pharma has 3 total employees.

  • What industry is Coegin Pharma in?

    Coegin Pharma’s primary industry is Biotechnology.

  • Is Coegin Pharma a private or public company?

    Coegin Pharma is a Public company.

  • What is Coegin Pharma’s stock symbol?

    The ticker symbol for Coegin Pharma is 7Z6.

  • What is the current stock price of Coegin Pharma?

    As of 13-Nov-2026 the stock price of Coegin Pharma is $0.19.

  • What is the current market cap of Coegin Pharma?

    The current market capitalization of Coegin Pharma is $5.76M.

  • What is Coegin Pharma’s current revenue?

    The trailing twelve month revenue for Coegin Pharma is $46.2K.

  • What is Coegin Pharma’s annual earnings per share (EPS)?

    Coegin Pharma’s EPS for 12 months was -$0.09.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process